Deltex Medical Group plc (AIM:DEMG)
London
· Delayed Price · Currency is GBP · Price in GBX 0.0240
-0.0110 (-31.43%)
Inactive · Last trade price
on Feb 20, 2025
Deltex Medical Group Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 1.78 | 1.78 | 2.48 | 2.26 | 2.4 | 4.26 | Upgrade
|
| Revenue | 1.78 | 1.78 | 2.48 | 2.26 | 2.4 | 4.26 | Upgrade
|
| Revenue Growth (YoY) | -25.26% | -28.44% | 9.87% | -5.80% | -43.66% | -14.11% | Upgrade
|
| Cost of Revenue | 0.67 | 0.65 | 0.64 | 0.68 | 0.76 | 0.97 | Upgrade
|
| Gross Profit | 1.11 | 1.13 | 1.84 | 1.58 | 1.64 | 3.28 | Upgrade
|
| Selling, General & Admin | 1.56 | 1.77 | 2.59 | 2.54 | 2.44 | 2.74 | Upgrade
|
| Research & Development | 0.4 | 0.22 | 0.23 | 0.21 | 0.25 | 0.45 | Upgrade
|
| Other Operating Expenses | -0.13 | -0.17 | -0.07 | -0.37 | -0.4 | -0.01 | Upgrade
|
| Operating Expenses | 1.82 | 1.81 | 2.79 | 2.38 | 2.27 | 3.18 | Upgrade
|
| Operating Income | -0.71 | -0.69 | -0.95 | -0.81 | -0.63 | 0.1 | Upgrade
|
| Interest Expense | -0.22 | -0.23 | -0.2 | -0.17 | -0.17 | -0.18 | Upgrade
|
| EBT Excluding Unusual Items | -0.93 | -0.92 | -1.15 | -0.98 | -0.8 | -0.07 | Upgrade
|
| Merger & Restructuring Charges | -0.12 | -0.12 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.22 | -0.04 | Upgrade
|
| Other Unusual Items | -0.25 | -0.25 | - | - | 0.23 | -0.1 | Upgrade
|
| Pretax Income | -1.29 | -1.28 | -1.15 | -0.98 | -0.79 | -0.21 | Upgrade
|
| Income Tax Expense | -0 | - | -0 | -0.01 | -0.01 | -0.05 | Upgrade
|
| Net Income | -1.29 | -1.28 | -1.15 | -0.97 | -0.79 | -0.16 | Upgrade
|
| Net Income to Common | -1.29 | -1.28 | -1.15 | -0.97 | -0.79 | -0.16 | Upgrade
|
| Shares Outstanding (Basic) | 1,776 | 1,181 | 685 | 581 | 526 | 510 | Upgrade
|
| Shares Outstanding (Diluted) | 1,776 | 1,181 | 685 | 581 | 526 | 510 | Upgrade
|
| Shares Change (YoY) | 153.28% | 72.32% | 18.04% | 10.31% | 3.29% | 8.11% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -1.33 | -1.2 | -0.68 | -0.31 | -0.07 | 0.6 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | Upgrade
|
| Gross Margin | 62.21% | 63.34% | 74.09% | 69.72% | 68.43% | 77.11% | Upgrade
|
| Operating Margin | -39.92% | -38.63% | -38.15% | -35.64% | -26.11% | 2.42% | Upgrade
|
| Profit Margin | -72.49% | -72.18% | -46.13% | -42.76% | -32.74% | -3.74% | Upgrade
|
| Free Cash Flow Margin | -74.56% | -67.79% | -27.24% | -13.90% | -3.09% | 14.07% | Upgrade
|
| EBITDA | -0.65 | -0.63 | -0.91 | -0.78 | -0.57 | 0.2 | Upgrade
|
| EBITDA Margin | -36.44% | -35.19% | -36.58% | -34.48% | -23.81% | 4.79% | Upgrade
|
| D&A For EBITDA | 0.06 | 0.06 | 0.04 | 0.03 | 0.06 | 0.1 | Upgrade
|
| EBIT | -0.71 | -0.69 | -0.95 | -0.81 | -0.63 | 0.1 | Upgrade
|
| EBIT Margin | -39.92% | -38.63% | -38.15% | -35.64% | -26.11% | 2.42% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.